Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures
Molecular Oncology · 2024
DOI: 10.1002/1878-0261.13617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von Ana Glenda Santarosa Vieira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Barretos Children's Cancer Hospital from Hospital de Amor, Brazil. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Germ Cell and Embryonal, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
microRNAs (miRNAs) are small endogenous noncoding RNAs, and alterations in their expression may contribute to oncogenesis. Discovering a unique miRNA pattern holds the potential for early detection and novel treatment possibilities in cancer. This study aimed to evaluate miRNA expression in pediatric patients with gonadal germ cell tumors (GCTs), focusing on characterizing the miRNA profiles of each histological subtype and identifying a distinct histological miRNA signature for a total of 42 samples of pediatric gonadal GCTs. The analysis revealed distinct miRNA expression profiles for all histological types, regardless of the primary site. We identified specific miRNA expression signatures for each histological type, including 34 miRNAs for dysgerminomas, 13 for embryonal carcinomas, 25 for yolk sac tumors, and one for immature teratoma, compared to healthy controls. Furthermore, we identified 26 miRNAs that were commonly expressed in malignant tumors, with six miRNAs (miR‐302a‐3p, miR‐302b‐3p, miR‐371a‐5p, miR‐372‐3p, miR‐373‐3p, and miR‐367‐3p) showing significant overexpression. Notably, miR‐302b‐3p exhibited a significant association with all the evaluated clinical features. Our findings suggest that miRNAs have the potential to aid in the diagnosis, prognosis, and management of patients with malignant GCTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barretos Children's Cancer Hospital from Hospital de Amor, Brazil.
- Brazilian Childhood Germ Cell Tumor Study Group, The Brazilian Pediatric Oncology Society (SOBOPE), São Paulo, Brazil.
- Pediatric Cancerology's Department of Santa Casa de Misericórdia de Santos, Brazil.
- Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil.
- Department of Pathology, Barretos Cancer Hospital, Brazil.
- Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, Portugal.
ORCID-Profile: Ana Glenda Santarosa Vieira
Zitieren
APA
Santarosa Vieira, A. G., da Silva, L. S., Albino da Silva, E. C., Laus, A. C., Faria, T. M. V., van Helvoort Lengert, A., Martins, G. E., de Oliveira, M. A., Reis, R. M., Lopes, L. F., & Pinto, M. T. (2024). Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures. Molecular Oncology. https://doi.org/10.1002/1878-0261.13617
Vancouver
Santarosa Vieira AG, da Silva LS, Albino da Silva EC, Laus AC, Faria TMV, van Helvoort Lengert A, et al. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures. Molecular Oncology. 2024. doi:10.1002/1878-0261.13617
BibTeX
@article{SantarosaVieira2024,
author = {Santarosa Vieira, Ana Glenda and da Silva, Luciane Sussuchi and Albino da Silva, Eduardo Caetano and Laus, Ana Carolina and Faria, Thaíssa Maria Veiga and van Helvoort Lengert, André and Martins, Gisele Eiras and de Oliveira, Marco Antônio and Reis, Rui Manuel and Lopes, Luiz Fernando and Pinto, Mariana Tomazini},
title = {Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures},
journal = {Molecular Oncology},
year = {2024},
doi = {10.1002/1878-0261.13617}
}
EUVIMED